Roswell Park-led effort found increased levels of serum glutamate in both primary and metastatic prostate tumors
Tuesday, October 23, 2012
BUFFALO — Research out of Roswell Park Cancer Institute (RPCI) supports the adoption of a new biomarker to measure the aggressiveness of primary prostate tumors.
Morning of camaraderie and support planned for Saturday, November 3
Monday, October 22, 2012
BUFFALO, NY — Roswell Park Cancer Institute (RPCI) invites lung cancer patients, their family members and their caregivers to attend the fourth annual Breath of Life Celebration Saturday, November 3 from 9 am to noon in RPCI’s Research Studies Center, located on Carlton Street at Elm...
America’s first cancer center, Bills partner to host prostate cancer screening clinic October 23 at Ralph Wilson Stadium
Thursday, October 4, 2012
WHAT: One in six men will be diagnosed with prostate cancer, but with early detection, about 90 percent of these cancers will be cured. Roswell Park Cancer Institute (RPCI) and the Buffalo Bills are encouraging men over 50, or those 40 and...
Monday, October 1, 2012
BUFFALO — Currently, 1 in 8 U.S. women will be diagnosed with breast cancer, and nearly 40,000 will die from the disease this year. But thanks to increased early detection and treatment advances, the mortality rate for cancer has dropped 30 percent in the last two decades. Throughout October...
Peptide vaccine targets cancer survival protein, putting tumor cells in a Catch 22
Thursday, September 27, 2012
BUFFALO — A new clinical research study at Roswell Park Cancer Institute (RPCI) will test a first-of-its-kind cancer “vaccine” that may prove effective against many forms of solid-tumor cancers. The vaccine, to be investigated in a trial involving patients with brain cancer,...
Tuesday, September 25, 2012
BUFFALO — The Roswell Park Alliance Foundation, a not-for-profit that manages all donations made to Roswell Park Cancer Institute (RPCI), recently awarded scientific research grants totaling nearly $800,000 to RPCI scientists and clinicians. The grants range from $10,000 to $100,000 and...
Camptothecin analog FL118 shown to inhibit production of key cancer survival genes
Thursday, September 20, 2012
BUFFALO — Some 500,000 people die of cancer in the United States each year, often because their cancers have become resistant to approved therapies. Scientists at Roswell Park Cancer Institute (RPCI) have made headway in the effort to overcome resistance to treatment, publishing findings...
Majority of those surveyed support policies prohibiting smoking anywhere in multi-tenant residential buildings
Monday, September 10, 2012
BUFFALO — A majority of Americans who live in multi-unit housing have adopted smoke-free rules in their private homes but millions remain involuntarily exposed to secondhand smoke in this environment, according to a study published in the most recent issue of the American Journal of Public...
Second annual Cruisin’ for a Cure car show comes to RPCI campus September 22
Thursday, September 6, 2012
WHAT: Prostate cancer has a disproportional impact on African-American men, who are 1.5 times more likely to develop prostate cancer and 2-3 times more likely to die of the disease than white men. Prostate cancer is also the most...
Approach uses data from large genomic studies, robust sequencing to identify causal variants
Wednesday, September 5, 2012
BUFFALO — With the ability to sequence human genes comes an onslaught of raw material about the genetic characteristics that distinguish us, and wading through these reserves of data poses a major challenge for life scientists. Researchers at Roswell Park Cancer Institute (RPCI) and the...